Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems

K-Number: K240867 · 2025-02-11

ApplicantRoche Molecular Systems, Inc.
Decision Date2025-02-11
Product CodeQQX
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is the device name listed in this FDA 510(k) record. The listed applicant is Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2025-02-11 under 510(k) number K240867. The device is classified under product code QQX. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?

cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is a medical device that received FDA 510(k) clearance on 2025-02-11. The listed applicant is Roche Molecular Systems, Inc.. The 510(k) number is K240867.

When did cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems receive FDA 510(k) clearance?

cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems received FDA 510(k) clearance on 2025-02-11, under 510(k) number K240867.

Who is the listed applicant for cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?

The FDA 510(k) record lists Roche Molecular Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems?

The FDA product code for cobas® SARS-CoV-2 Qualitative for use on the cobas® 5800/6800/8800 Systems is QQX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2RECRUITING

Other records listing Roche Molecular Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260021cobas® BV/CVK260917cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systemsPMA P190028KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUSK253759cobas liat CT/NG/MG nucleic acid testK253756cobas liat CT/NG nucleic acid testPMA P140023Somatic gene mutation detection system

View all 47 devices →

Related Devices (Code: QQX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K243396Aptima SARS-CoV-2 AssayHologic, Inc.K242109Xpert® Xpress CoV-2 plus (XPRS-COV2-10)Cepheid®K241580Alinity m SARS-CoV-2 AMP Kit (09N78-096); Alinity m SARS-CoV-2 CTRL Kit (09N78-086)Abbott MolecularK233453Applied Biosystems™ TaqPath™ COVID-19 Diagnostic PCR KitLife Technologies CorporationK230440Xpert® Xpress CoV-2 plusCepheid®K231306cobas SARS-CoV-2 Qualitative for use on the cobas 5800/6800/8800 SystemsRoche Molecular Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑